Abstract
ACETYLCHOLINE activates both nicotinic and muscarinic receptors in the central nervous system1. Although the action of acetylcholine at muscarinic receptors has been well characterized, relatively little is known at the cellular level concerning nicotinic receptor stimulation in brain. Central nicotinic receptors have been implicated in Alzheimer's disease2, seizure activity3, the generation of slow-wave theta rhythm in the hippocampus4 and the potential abuse liability of nicotine5. At the neuronal level, nicotinic agonists have been most often associated with postsynaptically mediated excitation and membrane depolarization at various sites, including Renshaw spinal motoneurons6, locus coeruleus7 and the medial habenular nucleus8. Nicotine acting presynaptically can produce either excitation or inhibition indirectly through the release of endogeneous transmitters or modulators9–12. Whereas a direct inhibitory effect of nicotine has been suggested by one in vivo extracellular recording study in rat cerebellar Purkinje neurons13, the mechanism(s) underlying this action is not yet known. We now report our findings obtained using in vitro intracellular methods in a submerged brain slice preparation in which application of nicotinic agonists to rat dorsolateral septal neurons reveal a direct membrane hyperpolarization mediated by an increase in potassium conductance.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Krnjevic, K. Physiol. Rev. 54, 418–540 (1974).
Whitehouse, P. J. et al. Arch. Neurol. 45, 722–724 (1988).
Miner, L. L., Marks, M. J. & Collins, A. L. J. Pharmacol. expt. Ther. 239, 853–860 (1986).
Bland, B. H. & Colom, L. V. Brain Res. 440, 167–171 (1988).
Byrne, G. Science 240, 1143 (1988).
Curtis, D. R. & Ryall, R. W. Expl Brain Res. 2, 6–80 (1966).
Egan, T. M. & North, R. A. Neuroscience 19, 565–571 (1986).
McCormick, D. A. & Prince, D. A. J. Neurosci. 7, 742–752 (1987).
Chesselet, M. F. Neuroscience 12, 347–375 (1984).
Westfall, T. C. Neuropharmacology 13, 693–700 (1974).
Hery, F., Bourgoin, S., Hamon, M., Ternaux, J. P. & Glowinski, J. Naunyn Schmiedebergs Arch. Pharmac. 396, 91–97 (1977).
Freund, R. K., Jungschaffer, D. A., Collins, A. C. & Wehner, J. M. Brain Res. 453, 215–220 (1988).
de la Garza, R., McGuire, T. J., Freedman, R. & Hoffer, B. J. Neurosci. Lett. 80, 303–308 (1987).
DeFrance, J. F. in The Septal Nuclei (ed. DeFrance, J. F.) 185–227 (Plenum, New York, 1976).
McLennan, H. & Miller, J. J. J. Physiol. Lond. 237, 607–624 (1974).
Swanson, L. W. & Cowan, W. M. J. comp. Neurol. 186, 621–656 (1979).
Green, J. D. & Arduini, A. J. Neurophysiol. 17, 553–557 (1954).
Stumpf, C., Petsche, H. & Gogolak, G. Electroenceph. clin. Neurophysiol. 14, 212–219 (1962).
Bland, S. K. & Bland, B. H. Brain Res. 375, 102–116 (1986).
Harkmark, W., Mellgren, S. I. & Srebo, B. Brain Res. 95, 281–289 (1975).
Paxinos, G. & Watson, C. The Rat Brain in Stereotaxic Co-ordinates Plate 17 (Academic, City, 1986).
Rainbow, T. C., Schwartz, R. D., Parsons, B. & Kellar, K. Neurosci. Lett. 50, 193–196 (1984).
Clarke, P. B. S., Schwartz, R. D., Paul, S. M., Pert, C. B. & Pert, A. J. Neurosci. 5, 1307–1315 (1985).
Schwartz, R. D. Life Sci. 38, 2111–2119 (1986).
Nonaka, R. & Moroh, I. Brain Res. 296, 295–303 (1984).
Satoh, K. & Fibiger, H. C. J. comp. Neurol. 253, 277–302 (1986).
Hallanger, A. E. & Wainer, B. H. J. comp. Neurol. 274, 483–515 (1988).
DeFrance, J. F., Yoshihara, H., McCrea, R. A. & Kitai, S. T. Expl Neurol. 48, 502–523 (1975).
Segal, M. Life Sci. 14, 1345–1351 (1974).
Hasuo, H., Gallagher, J. P. & Shinnick-Gallagher, P. Brain Res. 438, 323–327 (1988).
Wong, L. A., Hasuo, H. & Gallagher, J. P. Soc. Neurosci. Abstr. 13, 268 (1987).
Taylor, P. in The Pharmacological Basis of Therapeutics p 218 (Macmillan, New York, 1985).
Chiappinelli, V. A. Pharmac. Ther. 31, 1–32 (1985).
Loring, R. H., Andrews, D., Lane, W. & Zigmond, R. E. Brain Res. 385, 30–37 (1986).
Stevens, D. R., Gallagher, J. P. & Shinnick-Gallagher, P. Synapse 1, 184–190 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wong, L., Gallagher, J. A direct nicotinic receptor-mediated inhibition recorded intracellularly in vitro. Nature 341, 439–442 (1989). https://doi.org/10.1038/341439a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/341439a0
This article is cited by
-
Thymopoietin, a thymic polypeptide, potently interacts at muscle and neuronal nicotinic α-bungarotoxin receptors
Molecular Neurobiology (1992)
-
Desensitization of central cholinergic mechanisms and neuroadaptation to nicotine
Molecular Neurobiology (1990)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.